Clinical Trial Update: Stem Cell Transplant in Sickle Cell Disease and Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on hematopoietic stem cell transplantation for sickle cell disease and beta-thalassemia; the study is currently active but not rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia
• Sickle Cell Disease

Drugs mentioned

• Hematopoietic stem cell transplantation

Snippet

Sponsor: Columbia University | Conditions: Sickle Cell Disease, Beta Thalassemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING